In the pathology of RA, IL-6 can stimulate pannus formation through increased vascular endothelial growth factor expression and increase bone resorption as a result of osteoclastogenesis, as well as oxidative stress in leukocytes.129,130 TCZ is available in subcutaneous and intravenous formulations. Here, IL6 is linked to rheumatoid arthritis.